Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 2.57% is 135% above its 5-year average of -7.30%, near the high end of its 5-year range (-67.17%–25.53%).
5.63% above its 12-month average of 2.43%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 25.53%.
NET PROFIT MARGIN
2.57%
NET PROFIT MARGIN AVG TTM
2.43%
NET PROFIT MARGIN AVG 3Y
-6.75%
NET PROFIT MARGIN AVG 5Y
-7.30%
NET PROFIT MARGIN AVG 10Y
-8.30%
NET PROFIT MARGIN AVG 15Y
-5.14%
NET PROFIT MARGIN AVG 20Y
-4.04%
CURRENT VS TTM AVG
+5.63%
CURRENT VS 3Y AVG
+138.05%
CURRENT VS 5Y AVG
+135.22%
CURRENT VS 10Y AVG
+130.97%
CURRENT VS 15Y AVG
+149.97%
CURRENT VS 20Y AVG
+163.56%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 786 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
ImmuCell Corporation
Market Cap
$89.34M
Net Profit Margin
2.57%
TTM Avg
2.43%
3Y Avg
-6.75%
5Y Avg
-7.30%
Market Cap
$89.36M
Net Profit Margin
7051.24%
TTM Avg
-5065.26%
3Y Avg
-2532.63%
5Y Avg
-1688.42%
Market Cap
$89.68M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$89.60M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$90.25M
Net Profit Margin
-39.96%
TTM Avg
-45.40%
3Y Avg
-116.56%
5Y Avg
-242.44%
Market Cap
$90.96M
Net Profit Margin
0.00%
TTM Avg
-9.81%
3Y Avg
-113.18%
5Y Avg
-75.45%
Market Cap
$93.48M
Net Profit Margin
-1.41%
TTM Avg
0.88%
3Y Avg
1.31%
5Y Avg
1.31%
Market Cap
$91.23M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$87.20M
Net Profit Margin
-269.42%
TTM Avg
-19.58%
3Y Avg
-904.79%
5Y Avg
-881.91%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ImmuCell Corporation (ICCC) | $89.34M | 2.57% | 2.43% | -6.75% | -7.30% |
| Rallybio Corporation (RLYB)vs › | $89.36M | 7051.24% | -5065.26% | -2532.63% | -1688.42% |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $89.68M | 0.00% | 0.00% | 0.00% | 0.00% |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $89.60M | 0.00% | 0.00% | 0.00% | 0.00% |
| electroCore, Inc. (ECOR)vs › | $90.25M | -39.96% | -45.40% | -116.56% | -242.44% |
| Equillium, Inc. (EQ)vs › | $90.96M | 0.00% | -9.81% | -113.18% | -75.45% |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $93.48M | -1.41% | 0.88% | 1.31% | 1.31% |
| Biomea Fusion, Inc. (BMEA)vs › | $91.23M | 0.00% | 0.00% | 0.00% | 0.00% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $87.20M | -269.42% | -19.58% | -904.79% | -881.91% |
| CareCloud, Inc. (CCLD)vs › | $86.90M | 6.21% | 8.02% | -5.41% | -4.66% |
Operating Margin
12.6%
Net Profit Margin
2.6%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 25.53% |
| 2026-03-31 | 18.75% |
| 2025-12-31 | -37.36% |
| 2025-09-30 | -2.54% |
| 2025-06-30 | 7.79% |
| 2025-03-31 | 17.94% |
| 2024-12-31 | 6.64% |
| 2024-09-30 | -11.67% |
| 2024-06-30 | -27.99% |
| 2024-03-31 | -6.03% |
| 2023-12-31 | -22.37% |
| 2023-09-30 | -17.42% |
| 2023-06-30 | -39.06% |
| 2023-03-31 | -67.17% |
| 2022-12-31 | -42.65% |
| 2022-09-30 | -13.66% |
| 2022-06-30 | -17.72% |
| 2022-03-31 | 8.56% |
| 2021-12-31 | 1.36% |
| 2021-09-30 | 2.87% |
| 2021-06-30 | 3.11% |
| 2021-03-31 | -10.74% |
| 2020-12-31 | 5.05% |
| 2020-09-30 | -8.67% |
| 2020-06-30 | -25.82% |
| 2020-03-31 | -2.49% |
| 2019-12-31 | -8.55% |
| 2019-09-30 | -16.92% |
| 2019-06-30 | -23.14% |
| 2019-03-31 | 3.28% |
| 2018-12-31 | -35.82% |
| 2018-09-30 | -11.61% |
| 2018-06-30 | -26.48% |
| 2018-03-31 | -7.67% |
| 2017-12-31 | -6.22% |
| 2017-09-30 | -16.93% |
| 2017-06-30 | -12.48% |
| 2017-03-31 | 16.49% |
| 2016-12-31 | 1.37% |
| 2016-09-30 | 1.77% |
| 2016-06-30 | -0.39% |
| 2016-03-31 | 15.15% |
| 2015-12-31 | 10.72% |
| 2015-09-30 | 14.21% |
| 2015-06-30 | 4.80% |
| 2015-03-31 | 15.45% |
| 2014-12-31 | 5.92% |
| 2014-09-30 | 0.58% |
| 2014-06-30 | -19.15% |
| 2014-03-31 | -0.64% |
| 2013-12-31 | -9.67% |
| 2013-09-30 | 4.64% |
| 2013-06-30 | 0.47% |
| 2013-03-31 | 11.06% |
| 2012-12-31 | -1.19% |
| 2012-09-30 | -5.90% |
| 2012-06-30 | 1.29% |
| 2012-03-31 | 9.01% |
| 2011-12-31 | -0.04% |
| 2011-09-30 | -12.72% |
| 2011-06-30 | -20.70% |
| 2011-03-31 | -1.49% |
| 2010-12-31 | -11.41% |
| 2010-09-30 | -22.56% |
| 2010-06-30 | -0.60% |
| 2010-03-31 | -4.06% |
| 2009-12-31 | -1.46% |
| 2009-09-30 | -1.87% |
| 2009-06-30 | -14.76% |
| 2009-03-31 | -2.37% |
| 2008-12-31 | -3.20% |
| 2008-09-30 | -29.05% |
| 2008-06-30 | -28.78% |
| 2008-03-31 | 4.75% |
| 2007-12-31 | 4.77% |
| 2007-09-30 | 18.32% |
| 2007-06-30 | -6.28% |
| 2007-03-31 | 17.71% |
| 2006-12-31 | 12.65% |
| 2006-09-30 | 14.32% |
| 2006-06-30 | 1.90% |
| 2006-03-31 | 19.79% |
| 2005-12-31 | 18.98% |
| 2005-09-30 | 10.57% |
| 2005-06-30 | 8.05% |
| 2005-03-31 | 16.26% |
| 2004-12-31 | 3.65% |
| 2004-09-30 | -0.60% |
| 2004-06-30 | -8.72% |
| 2004-03-31 | 13.87% |
| 2003-12-31 | -15.52% |
| 2003-09-30 | -4.79% |
| 2003-06-30 | -20.19% |
| 2003-03-31 | 67.74% |
| 2002-12-31 | 52.73% |
| 2002-09-30 | 2.20% |
